Clinical Trial Update: Sildenafil Study to Treat Idiopathic Pulmonary Fibrosis [Phase 2]

View source ↗

Summary

A Phase 2 trial of sildenafil for idiopathic pulmonary fibrosis has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis
• Pulmonary Hypertension

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Alveolitis, Fibrosing, Fibrosis, Pulmonary | Phase 2 | Status: COMPLETED | Results posted: 2014-10-06